semaglutide journey week by week Results Timeline: What to Expect Each GLP-1 Journey: Week One |

Titration and tolerance affect the pace of results

The high variability in adherence and patient management in real-world scenarios likely dilutes the potential maximum efficacy seen under controlled clinical trial conditions

The International Foundation for Employee Benefit Plans (IFEBP) survey was somewhere in between KFF and Mercer, estimating that about 34% of US employers (no employee count specified) offered GLP-1 drugs for weight loss purposes in 2024, which is up 8% from 26% in 2023

For precise unit measurements , even a 2-3 unit error can shift your actual dose meaningfully at higher concentrations

It doesn't make sense to me because we just don't know enough about these drugs and the benefits versus the potential risks long-term

Women with PCOS often face delays in accessing these medications, disrupting their treatment plans